Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / FOLH1B

FOLH1B

Basics

Aliases:
This biomarker is also known as:
  • Cell growth-inhibiting gene 26 protein,
  • folate hydrolase 1B,
  • folate hydrolase 2,
  • Prostate-specific membrane antigen-like protein,
  • GCP3,
  • PSMAL,
  • N-acetylated-alpha-linked-acidic dipeptidase,
  • FOLHP,
  • putative N-acetylated-alpha-linked acidic dipeptidase,
  • PSMA-LIKE,
  • EC 3.4.-.-,
  • Q9HBA9,
  • cell growth-inhibiting gene 26 protein,
  • PSM,
  • NAALADase,
  • GCPIII,
  • folate hydrolase pseudogene,
  • glutamate carboxypeptidase III,
  • prostate-specific membrane antigen-like protein,
  • Putative folate hydrolase 1B,
  • putative folate hydrolase 1B,
  • FOLH2,

View in BioMuta

Description…

FOLH1B, or PSMAL, is a cytoplasmic protein. It has been found in the kidney and liver, and has not been detected in the prostate. GO annotations related to this gene include metallopeptidase activity and dipeptidase activity.

Attributes

QA State: Curated
Type: Protein
Short Name:
HGNC Name: FOLH1B

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Ovary

Attributes

Phase: One
QA State: Under Review

Overview

No additional ovarian data available.

Performance Comment

FOLH1B (PSMAL) was one of 50 tumor vasculature-associated genes with transmembrane or secreted protein products identified through expression profiling of ovarian cancer vascular cells. These 50 tumor vascular markers (TVMs) also had low or no expression in normal tissues. FOLH1B (PSMAL) was not in the group of 13 selected for further validation.

Prostate

Attributes

Phase: One
QA State: Under Review

Overview

Performance Comment

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement